Tecvayli and Darzalex combination shows unprecedented progression-free survival in relapsed/refractory multiple myeloma, ...

Researchers at the Children's Cancer Institute and UNSW Sydney have tested a new way of treating childhood brain cancer by ...

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...

The MajesTEC-9 trial showed a 40% reduced risk of death and a 71% reduced risk of disease progression or death with ...

The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...

Adolescents with Human Immunodeficiency Virus (HIV) in Botswana, South Africa, Thailand, Uganda and the United States who ...

At Stanford, a treatment that aims magnetic pulses at the brain is showing results for people with treatment-resistant depression. It’s called SAINT, and here’s how it works.

Many clinical trials include a placebo group—participants who receive an inactive treatment—so researchers can compare ...

When you cease taking your PPI, you might observe that indigestion symptoms return for a short period, and sometimes they can ...

Its spores are highly resistant to heat and many disinfectants, making them easily transmissible in hospitals.

Researchers discovered a possible weakness in the deadly hospital superbug C. auris that could lead to new treatments for the ...

Russell has a PhD in the history of medicine, violence, and colonialism. His research has explored topics including ethics, science governance, and medical involvement in violent contexts. Russell has ...